Microarray experiments 2
Total RNA was isolated using RNeasy mini kit (Qiagen) according to the manufacturer's 3 instructions. Concentration, purity and integrity of the isolated RNA were evaluated using a 4
Nanodrop spectrophotometer and an Agilent 2100 Bioanalyzer. Ten µg of total RNA were used 5 for cDNA synthesis using the Superscript Indirect cDNA labeling kit (Invitrogen), according to 6 manufacturer's instructions. cDNA samples were labeled with Cy3 or Cy5 dyes (Amersham 7 Biosciences). Purified fluorescent cDNAs were hybridized to C. albicans oligonucleotide 8 microarrays (Eurogentec) according to manufacturer's instructions. Arrays were scanned with 9
an Axon 4000A scanner (Molecular Devices) and data were acquired and analyzed using 10 Genepix Pro 5.0 (Molecular Devices). For each comparison, two biological replicates were 11 used and each biological replicate was subjected to technical replicates with dye-swaps. Data 12 normalization (Lowess) and statistical analysis (Student t-test) were performed using 13 Genespring GX 7.3 (Agilent Technologies). Genes regulated, by at least a 1.5-fold with a p-14 value < 0.05, were considered significant. Microarray data have been deposited at 15
ArrayExpress under accession number E-MEXP-3084. Normalized data are available in 16 Supplemental Table 2 . Gene ontology analyses were performed using tools available at the 17
Candida Genome Database (2). Pearson correlation coefficient between ApoEdpL-W and 18
myo5∆ microarrays experiments was calculated using R software based on ratios of all genes 19 for which a ratio was available for each experiment. 20 21
qRT-PCR experiments 22
Total RNA was isolated using RNeasy mini kit (Qiagen) according to the manufacturer's 23 instructions and treated with Turbo DNase kit (Ambion, Applied Biosystems) to ensure the 24 absence of genomic DNA contamination. Concentration, purity and integrity of the isolated 25 evaluating cell permeability, cells were exposed to ApoEdpL-W-Fluo in the presence of 23 propidium iodide at 10 µg/ml (Sigma) and visualized after 1 h at 30°C. Previous reports have shown that ApoEdpL-W has a strong anti-viral and anti-bacterial activity 6 (35). Here, we investigated the antifungal activity of ApoEdpL-W towards the C. albicans 7 standard laboratory strain SC5314 by determining the MIC using the broth dilution method in 8 RPMI medium and SD 2% glucose medium, with or without buffering to pH 7. Results 9 summarized in Table 3 showed MIC90s ranging from 3.75 µM to 7.5µM in these media, 10 suggesting that medium and pH had little influence on the antifungal activity of ApoEdpL-W. 11
These MICs were compared to those of other CAFPs, namely Hst-5 and Magainin 2. Because 12 of their salt sensitivity Hst-5 and Magainin 2 are inefficient in usual laboratory media such as 13 SD 2% glucose or RPMI (27, 63, 66) . Therefore MICs were determined through incubation of 14 C. albicans SC5314 cells in 10 mM PPB with increasing concentrations of peptides followed 15 by cfu counting. Results presented in Table 3 showed that, in these conditions, the MIC90 of 16 ApoEdpL-W was similar to those in growth media, and was 4-8x lower than MIC90s obtained 17
for Hst-5 and Magainin 2. For these latter peptides, MIC90s of 10 to 20 µM were obtained, 18 similar to what has been reported by others (24, 29, 56). In addition, ApoEdpL-W was 19 fungicidal to C. albicans cells. Indeed, killing curves showed that, at the MIC90, killing was 20 very rapid with more than 95% of the C. albicans cells being killed after 5 min of incubation 21 and no viable cells being detected after 30 min exposure (Fig. 1) . In contrast, when the 22 concentration was reduced 2-fold, ApoEdpL-W remained fungistatic (Fig. 1) . 23
ApoEdpL-W was also tested for its efficacy towards a panel of 91 clinical strains of various 24 pathogenic Candida species (C. albicans, Candida parapsilosis, Candida tropicalis, Candidaglabrata) with a wide range of resistance/sensitivity to antifungals in clinical use 1 (Supplemental Table 1 ; (8)). Results presented in Table 4 showed that ApoEdpL-W was 2 efficient against a majority of the tested strains. Yet, ApoEdpL-W was much less effective 3 against C. glabrata with most of the MICs against these isolates being over 20 µM (Table 4) , 4 whereas C. tropicalis isolates appeared to be exquisitely sensitive to ApoEdpL-W. Overall, a 5 chi2 test confirmed a significant difference in MIC distributions between species (P value < 6 2.2e -16 ). Yet, no correlation with the MICs of the antifungals in clinical use already determined 7 for these strains (8) was observed. Taken together, these data showed that ApoEdpL-W was 8 fungicidal against C. albicans and other pathogenic yeasts with the exception of C. glabrata 9 and was more potent than other antifungal peptides such as Hst-5 and Magainin 2. 10 
11

Antifungal activity of ApoEdpL-W on Candida albicans biofilms 12
Biofilm formation by Candida species represents a major threat in the clinical setting. Thus, the 13 antifungal activity of ApoEdpL-W was tested on C. albicans preformed biofilms. Biofilms 14 developed for 1, 5 or 18h in microtiter plates in the absence of antifungal peptide were exposed 15 to increasing levels of ApoEdpL-W for an additional 24h. When applied on 1h adhesion-stage 16 biofilms, ApoEdpL-W was able to completely inhibit biofilm growth at concentrations equal or 17 above the MIC90 determined for planktonic cells (data not shown). On 5h early-stage biofilms, 18
ApoEdpL-W was able to partially inhibit biofilm formation ( Fig. 2A) . The biofilm metabolic 19 activity measured after 24h of incubation with ApoEdpL-W was reduced to 60% of the control 20 at the planktonic MIC90 and down to 40% by increasing concentration to 4 times the 21 planktonic MIC90. Exposure of 18 h mature biofilms to ApoEdpL-W resulted in a slight 22 reduction of biofilm metabolic activity corresponding to 80% of the control when 4 times the 23 planktonic MIC90 was used (data not shown).1 medical devices such as catheters. Thus, the antifungal activity of ApoEdpL-W on biofilms 2 formed on 2 polymer materials used in medical devices, namely polyurethane (PU) and 3 polydiméthylsiloxane (PDMS), was also tested. These materials were coated with ApoEdpL-W 4 as described in Materials and Methods and used as substrates for C. albicans biofilm formation. 5
After 24h of incubation, macroscopic observation revealed that C. albicans strain SC5314 was 6 able to form a biofilm on the coated materials, but the biofilms had a strong tendency to detach 7 (data not shown). After 72h of incubation, an increased tendency of the biofilms to detach from 8 the coated materials was observed (Fig. 2B, lower panel) . This was apparent in the 3 to 5-fold 9 reduction of the metabolic activity of biofilms formed on the ApoEdpL-W coated materials 10 relative to uncoated materials (Fig. 2B) . Therefore, coating of PU and PDMS with ApoEdpL-11 W appeared to promote the formation of loose C. albicans biofilms rather than fully prevent 12 biofilm formation. Similar experiments were performed with a FITC-labeled derivative of The antifungal activity of Hst-5 is susceptible to a variety of treatments that interfere with its 22 binding to the cell wall, cytoplasmic translocation or eventual killing of C. albicans cells 23 through ionic imbalance (14, 30, 36, 60, 66) . These treatments have also been shown to 24
interfere with the activity of other CAFPs. Therefore, we tested whether they influenced 1 ApoEdpL-W antifungal activity. 2
Binding of Hst-5 to both cell wall beta-glucans and the cell wall-bound Ssa2 heat-shock protein 3 has been shown to contribute to its activity as C. albicans SSA2 knock-out mutants and 4 caspofungin-treated C. albicans cells show decreased sensitivity to this CAFP (30, 60). 5
ApoEdpL-W MICs of a C. albicans SSA2 knock-out mutant (ssa2∆, Table 1 ) and a 6 complemented strain (ssa2∆/SSA2, Table 1 ) were determined. They were similar to those 7 obtained for wild-type C. albicans strains (data not shown) suggesting that Ssa2 did not 8 contribute significantly to C. albicans susceptibility to ApoEdpL-W. In contrast, pre-incubation 9
of ApoEdpL-W with laminarin β-1,3 glucan prior to incubation with C. albicans cells fully 10 inhibited the antifungal activity of ApoEdpL-W (Fig. 3) . Laminarin was more potent at 11 inhibiting ApoEdpL-W activity than Hst-5 activity (Fig. 3) and the inhibition was dose-12 dependent, with increased levels of laminarin required to inhibit increased levels of ApoEdpL-13 W (data not shown). Importantly, ApoEdpL-W showed some synergy with caspofungin, an 14 inhibitor of cell wall beta-glucan synthesis (FIC = 0.465). This was in contrast to what has been 15 observed for Hst-5 whose activity is impaired by caspofungin treatment (30) suggesting that 16 beta-glucans contribute to trap ApoEdpL-W in the cell wall rather than provide a path for 17
ApoEdpL-W entry into C. albicans cells. 18
Results presented above suggested that ApoEdpL-W was less susceptible to physio-chemical 19 variations than other CAFPs, as it was active in a variety of media (Table 3) . Therefore, the 20 impact of known antagonists of CAFP activity on ApoEdpL-W activity was tested. Results 21 presented in Fig. 3 showed that ApoEdpL-W antifungal activity was not prevented by 100 mM 22 NaCl while this was the case for Hst-5 activity (14, 66) , suggesting that ionic imbalance was 23 not a determining factor for ApoEdpL-W antifungal action on C. albicans cells. Similarly, 24 NaN 3 , that has been proposed to protect against Hst-5 by triggering ATP depletion and alteringmembrane fluidity (36), did not have a protective effect against ApoEdpL-W (Fig. 3) . Taken  1 together, these data suggested that the mode-of-action of ApoEdpL-W differed from that of 2 Hst-5 and possibly that of other CAFPs. 3 4
Intracellular localization of ApoEdpL-W 5
In order to investigate the mode-of-action of ApoEdpL-W, we assessed its localization in C. 6 albicans cells using ApoEdpL-W-Fluo, which showed similar MIC90 as native ApoEdpL-W 7 against C. albicans SC5314 (Table 3) . C. albicans SC5314 cells were exposed to sub-inhibitory 8 concentrations of ApoEdpL-W-Fluo (5 µM) for different durations and observed by 9 fluorescence microscopy. The fluorescent peptide was shown to originally bind to the cell 10 surface, accumulate within intracellular organelles after 30 min for 33% of the cells, reaching 11 66% to 87% after 60 min, and be exclusively localized to these organelles after 2 hours ( 
W. 6
In order to get further insights in the antifungal mode-of-action of ApoEdpL-W, we performed 7 a gene expression analysis of C. albicans SC5314 planktonic cells exposed to ApoEdpL-W. 8
Exponentially-growing C. albicans SC5314 cells in SD 2% glucose at 30°C medium were 9 exposed to 2.5 µM ApoEdpL-W and samples were collected after 10 and 30 min. for transcript 10
profiling. The concentration of ApoEdpL-W that was used was sub-lethal ie that it lead to a 11 reduction in the C. albicans growth rate but did not result in any massive cell killing ( Table 2 ). After 30 min. of exposure, 48 genes were up-regulated and 26 were 17 down-regulated in response to ApoEdpL-W (Supplementary Table 2 ). Fifteen genes were up-18 regulated and 5 were down-regulated at both time points and are listed in Table 5 . Gene 19 ontology analysis of the differentially regulated genes indicated a statistically significant over-20 representation of genes encoding amino-acid transporters. These genes represented one-third of 21 the genes up regulated at both time points (GAP6, CAN1, GNP1, ORF19.4940 and GAP1) and 22
were among the genes that showed the highest up-regulation in response to ApoEdpL-W 23 (Table 5) . PTR2, a putative oligopeptide transporter was also strongly induced at both time 24 points, as well as RTA2 which encodes a putative long chain bases (LCBs)-floppase However, the inability of the C. albicans arginine-auxotrophic strain CEC361 to grow in the 21 absence of arginine and the presence of sub-lethal levels of ApoEdpL-W indicated that 22 degradation of the peptide was unlikely to account for the up-regulation of amino-acid 23 transporters (data not shown).
The CAN1, PTR2 and RTA2 genes do not contribute to tolerance or resistance to 1
ApoEdpL-W 2
As mentioned above, several of the amino acid transporter-encoding genes, namely CAN1, 3 PTR2, GAP1 and GAP6 were up-regulated in response to ApoEdpL-W or arginine. In contrast, 4 RTA2 appeared induced upon ApoEdpL-W exposure, and to a lower extent Hst-5, but not in 5 response to arginine (data not shown). Therefore, we tested whether RTA2 could contribute to 6 modulate the susceptibility of C. albicans to ApoEdpL-W. Strains with a deletion of the two 7 RTA2 alleles or over-expressing RTA2 were constructed and tested for their susceptibility to 8
ApoEdpL-W (strains CEC1545 and CEC1088, respectively). ApoEdpL-W MICs for these 9 strains were similar to those obtained for wild-type C. albicans strains suggesting that RTA2 10 did not contribute to C. albicans susceptibility to ApoEdpL-W. In addition, strains deleted for 11 both alleles of CAN1 or PTR2 (respectively CEC290 and CEC305; (7)) did not show any 12 increase resistance or sensitivity to ApoEdpL-W, indicating that neither CAN1 or PTR2 13 contributed to C. albicans susceptibility to ApoEdpL-W on their own (data not shown). 14 
15
Endocytosis of ApoEdpL-W contributes to its antifungal activity 16
Localization data presented above suggested that ApoEdpL-W was endocytosed and targeted to 17 the vacuole. Interestingly, half of the most up-regulated genes upon exposure of C. albicans 18 cells to ApoEdpL-W showed a strong up-regulation upon inactivation of the MYO5 gene 19 (Table 5) , that encodes a class I myosin necessary for efficient endocytosis in C. albicans (49). 20
Moreover the overall microarray data at 10 min showed a positive correlation with myo5 21 mutant transcriptome experiments (Pearson correlation coefficient = 0.33; p-value < 2.2e-22 16)(51), particularly obvious for the most up regulated genes. Yet, genes encoding amino acid 23 or oligopeptide transporters were not regulated in the myo5 mutant. Therefore, we tested the 24 susceptibility to ApoEdpL-W of a C. albicans strain defective for the MYO5 gene (COU46; Table 1 ). This strain had a 2-fold increase in ApoEdpL-W MIC90 (P-value=0.046) relative to 1 strain COU73 that harbours a functional MYO5 gene (Table 1) . Moreover, ApoEdpL-W-Fluo 2 persisted at the cell surface and did not accumulate in vacuoles of the COU46 strain (Fig. 4C) . alteration of membrane homeostasis could be secondary to the action of these peptides on 6 intracellular targets. Yet, the precise modes-of-action of the different antifungal peptides 7 remain to be elucidated. In this study, we have investigated a novel antifungal peptide derived 8 from human apoliprotein E. Strikingly, the sensitivity or resistance of ApoEdpL-W to a variety 9 of treatments suggests that its mode-of-action might be significantly different from that of other 10 cationic antifungal peptides (CAFPs) that have been investigated in detail such as Hst-5, 11
Magainin 2 or MUC7-20. Indeed, we have shown that ApoEdpL-W activity does not require 12 binding to the cell wall heat-shock protein Ssa2 and to beta-glucans, and is insensitive to azide, 13 high salt and changes in pH. Furthermore, we have shown that ApoEdpL-W accumulates 14 primarily in vacuoles and that vacuolar targeting contributes to ApoEdpL-W activity. This is in 15 marked contrast with observations made with Hst-5 that requires binding to glucans or Ssa2 16 (15, 30, 38, 60) , and shows azide, salt and pH (3, 36, 62). Finally, Hst5 targeting to the vacuole 17 is observed at low concentration only and is not required for activity (30, 42). These 18 requirements for Hst-5 activity are all thought to reflect its mode-of-action at the plasma 19 membrane. Therefore, the differences in behaviour that we have observed between Hst-5 and 20
ApoEdpL-W suggest in particular that ApoEdpL-W uses other routes than Hst-5 to reach the 21 plasma membrane, to penetrate cells and to exert its antifungal activity. This also appears to be 22 the case for other antifungal peptides. While Magainin 2 and Muc7-20 also show salt 23 sensitivity, other antifungal peptides such as Arenicin proved salt-insensitive (54). Differences 24 are also observed regarding azide sensitivity with Arenicin being sensitive (54) and Muc7-20being insensitive even though it is translocated intracellularly (6). Finally, human β-defensins 1 (hBD) show fungicidal activity in an energy-dependent manner, are salt sensitive, but do not 2 cause membrane disruption (64). Moreover, an additional energy-independent antifungal 3 mechanism has been revealed at higher concentrations of hBD-3 (64). Taken together these 4 data underscore the heterogeneity of behaviors of antifungal peptides and show that ApoEdpL-5 W is not an exception. This might reflect differences in the amino acid content, the positive 6 charge and the hydropathy of the different CAFPs at physiological pH even though rules still 7 need to emerge. Noticeably, ApoEdpL-W is mainly composed of tryptophan, arginine and 8 lysine residues and is likely to have a higher net positive charge than Hst-5 or Magainin 2. 9
Another major difference between Hst-5 and ApoEdpL-W lies in their apparent targeting to 10 different cellular compartments exemplified through the use of fluorescently-labelled 11 derivatives. While Hst-5 was shown to accumulate in the vacuole at low, non-lethal 12
concentrations, it is targeted to the cytoplasm at higher concentrations (42). This contrasts with 13
ApoEdpL-W that we have shown to associate with the cell surface and be subsequently 14 targeted to the vacuole at all concentrations tested, even though we cannot formally exclude 15 that the observed fluorescence is not in part due to free fluorescent label released from 16 degraded ApoEdpL-W. Moreover, our data using a C. albicans strain defective for the MYO5 17 that ApoEdpL-W could prevent biofilm formation when applied at early stages of biofilm 4 development but was less efficient when applied to mature biofilms. This relative inefficiency 5 might reflect the affinity of ApoEdpL-W for beta-glucans. Indeed, it has been shown that 6 soluble beta-(1,3)-glucans are major constituents of the extracellular matrix of C. albicans 7 biofilms that trap several antifungals, thus contributing to the intrinsic tolerance of biofilms 8 towards these antifungals (47, 48, 61). Therefore, it is likely that the same applies to ApoEdpL-9 W explaining the tolerance of mature C. albicans biofilms to this CAFP. Another application of 10 antifungal peptides could be in the coating of medical devices. Here, we have shown that the 11 coating with ApoEdpL-W of polymers used in the design of medical devices, namely PDMS 12 and PU, promotes the formation of C. albicans biofilms that have a strong tendency to detach 13 from the polymer, thus reducing the metabolic activity of the biofilm that remains attached to 14 the material by 60-70%. A similar reduction in biofilm formation has been observed when 15 PDMS grafted with Hst-5 was used while a higher reduction was observed when a derivative of 16
Hst-5 or low-molecular weight poly-D-lysine were used (12) . Whether a detachment of the 17 biofilm from the grafted surface was observed in this study is not known. These data suggest 18 that coating of materials with cationic antifungal peptides could prove useful. RTA2overR  GGGACCACTTTGTACAAGAAAGCTGGGTTAACTTACTATTTAAACAA  TGTATGTCATT  CEF3_F  GATCACAATTGGGTCCAAGG  CEF3_R  AGCAGCGGCAATCTTGTTAC  FRE7_F  TCGTTACGCCGATACTTGTG  FRE7_R  AATCTCCGTTTGCACCCTTC  MET15_F  GGAGATTGCCTCAAACTTGG  MET15_R  TGGTAACACCAGAAGCCAAC  LYS4_F  CGAAAACCAAACCAGGTGAC  LYS4_R  TGTGGCTGCTTGTTCTCTTG  GNP1_F  CGACTGATGCATTGGGTTAC  GNP1_R  AGCATCTGGTTTGGAAGCAC  GAP1_F  ATGGCACCTAAATGGACAGG  GAP1_R  TGAAAGCAACCACCTGTTTC  CAN1_F  GCCTTTACTGCTGCATTTGG  CAN1_R  TGAGATTAACCCTGCGGTTG  RTA2_F  GGGGTGGATATTTGTTCACG  RTA2_R  ACCCAAACTGGATGGAATGG  PTR2_F  GGGTTCATGTTTGGATCTGG  PTR2_R AACATGGACCGGCTTTGTAG orf19.1799_F TATCTGTGGGGTCATCATCG orf19.1799_R AGCACGATCAACGTATCCAC Laminarin: ApoEdpL-W-Fluo was preincubated with 5mg/ml laminarin for 1h prior to being 10 applied to cells. NaN 3 : cells were incubated with 10 mM NaN 3 for 1h prior to being exposed to 11
Legends to Figures
ApoEdpL-W-Fluo. Latrunculin A: cells were incubated with 50 µM latrunculin A for 1h prior 12 to being exposed to ApoEdpL-W-Fluo. 
